globe life inc. - GL
GL
Close Chg Chg %
108.77 0.25 0.23%
Closed Market
109.02
+0.25 (0.23%)
Volume: 553.50K
Last Updated:
Nov 21, 2024, 3:59 PM EDT
Company Overview: globe life inc. - GL
GL Key Data
| Open $109.52 | Day Range 108.21 - 109.79 |
| 52 Week Range 38.95 - 132.00 | Market Cap $9.13B |
| Shares Outstanding 83.95M | Public Float 83.43M |
| Beta 0.81 | Rev. Per Employee N/A |
| P/E Ratio 9.20 | EPS $11.90 |
| Yield 86.89% | Dividend $0.24 |
| EX-DIVIDEND DATE Jan 6, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 615.89K |
GL Performance
| 1 Week | -0.19% | ||
| 1 Month | 3.65% | ||
| 3 Months | 8.08% | ||
| 1 Year | -10.17% | ||
| 5 Years | 7.98% |
GL Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
13
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 131.091 | |
| Number of Ratings | 13 | Current Quarters Estimate | 3.117 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 12.338 | |
| Last Quarter’s Earnings | 3.49 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 10.65 | Next Fiscal Year Estimate | 13.564 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 10 | 9 | 10 | 10 |
| Mean Estimate | 3.12 | 3.23 | 12.34 | 13.56 |
| High Estimates | 3.17 | 3.28 | 12.41 | 13.70 |
| Low Estimate | 3.03 | 3.13 | 12.27 | 13.25 |
| Coefficient of Variance | 1.52 | 1.68 | 0.36 | 0.96 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 7 | 7 | 6 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 5 | 5 | 5 |
| UNDERWEIGHT | 1 | 1 | 1 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Globe Life Inc. - GL
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Globe Life Inc. - GL
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Nov 8, 2024 | Robert B. Mitchell EVP, General Counsel and CRO | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Nov 8, 2024 | Robert B. Mitchell EVP, General Counsel and CRO | 2,520 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $110.01 per share | 277,225.20 |
| Nov 8, 2024 | Robert B. Mitchell EVP, General Counsel and CRO | 9,466 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $108.78 per share | 1,029,711.48 |
| Nov 8, 2024 | Robert B. Mitchell EVP, General Counsel and CRO | 10,520 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $82.56 per share | 868,531.20 |
| Jun 7, 2024 | James Matthew Darden Co-Chairman & CEO; Director | 4,161 | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acq or disposition of issuer shs Non-derivative transaction at $81.81 per share | 340,411.41 |
| May 29, 2024 | Robert E. Hensley EVP & Chief Investment Officer | 7,290 | Open market or private purchase of non-derivative security Non-derivative transaction at $82.17 per share | 599,019.30 |
| May 23, 2024 | Frank M. Svoboda Co-Chairman & CEO; Director | 144,898 | Open market or private purchase of non-derivative security Non-derivative transaction at $82.27 per share | 11,920,758.46 |
| May 21, 2024 | Thomas Peter Kalmbach EVP & CFO | 18,080 | Open market or private purchase of non-derivative security Non-derivative transaction at $84.43 per share | 1,526,494.40 |
| May 1, 2024 | Frank M. Svoboda Co-Chairman & CEO; Director | 3,370 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $118.22 per share | 398,401.40 |
| May 1, 2024 | Frank M. Svoboda Co-Chairman & CEO; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 29, 2024 | Rebecca E. Zorn EVP & Chief Talent Officer | 10,220 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $77.3 per share | 790,006.00 |
| Apr 29, 2024 | Mark A. Blinn Director | 6,518 | Open market or private purchase of non-derivative security Non-derivative transaction at $76.77 per share | 500,386.86 |
| Apr 29, 2024 | David A. Rodriguez Director | 4,192 | Open market or private purchase of non-derivative security Non-derivative transaction at $79.72 per share | 334,186.24 |
| Apr 29, 2024 | Steven Paul Johnson Director | 14,766 | Open market or private purchase of non-derivative security Non-derivative transaction at $76.42 per share | 1,128,417.72 |
| Apr 29, 2024 | James Patrick Brannen Director | 7,030 | Open market or private purchase of non-derivative security Non-derivative transaction at $78.47 per share | 551,644.10 |
| Mar 1, 2024 | Michael Clay Majors EVP - Chief Strategy Officer | 24,700 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 1, 2024 | Michael Clay Majors EVP - Chief Strategy Officer | 41,151 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.4 per share | 5,283,788.40 |
| Mar 1, 2024 | Michael Clay Majors EVP - Chief Strategy Officer | 36,295 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 1, 2024 | Frank M. Svoboda Co-Chairman & CEO; Director | 72,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 1, 2024 | Christopher k. Tyler EVP and Chief Info Officer | 16,400 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |